Date Filed | Type | Description |
07/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/24/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
09/05/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/20/2016 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |
07/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/04/2013 |
4
| Marth William S (Director) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC
Txns:
| Bought 30,000 shares
@ $10.75, valued at
$322.5k
|
|
06/04/2013 |
4
| Marth William S (Director) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC
Txns:
| Bought 10,000 shares
@ $10.23, valued at
$102.3k
|
|
12/04/2012 |
4
| Marth William S (Director) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC
Txns:
| Bought 10,000 shares
@ $5, valued at
$50k
|
|
06/14/2012 |
4
| Marth William S (Director) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC
Txns:
| Granted 10,000 options to buy
@ $2.59, valued at
$25.9k
|
|
06/07/2012 |
4
| Marth William S (Director) has filed a Form 4 on ALBANY MOLECULAR RESEARCH INC
Txns:
| Granted 12,448 shares
@ $2.41, valued at
$30k
|
|
05/14/2012 |
3
| Marth William S (Director) has filed a Form 3 on ALBANY MOLECULAR RESEARCH INC |